Quick Answer
Sesamin Lipid Markers Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Moreover, emerging evidence demonstrates that ferroptosis occurs in endothelial cells, vascular smooth muscle cells, and macrophages within atherosclerotic lesions, suggesting a more direct contribution to plaque vulnerability and vascular dysfunction than other cell death pathways (;;).
Key Takeaways
- 01Moreover, emerging evidence demonstrates that ferroptosis occurs in endothelial cells, vascular smooth muscle cells, and macrophages within atherosclerotic lesions, suggesting a more direct contribution to plaque vulnerability and vascular dysfunction than other cell death pathways (;;). [Chen Xiaoying (2026)]
- 02Accumulating evidence indicates that mA modification and its regulatory enzymes, including METTL3 and FTO, play essential roles in vascular cell function, lipid metabolism, and inflammatory signaling during AS development (). [Chen Xiaoying (2026)]
- 03In this context, recent evidence indicates that SREBF1, traditionally known for its role in lipid metabolism, may exert context-dependent functions under oxidative stress, including regulation of ferroptosis-related antioxidant defenses (;). [Chen Xiaoying (2026)]
- 04Fan and Watanabe, 2022 Libby, 2021 Hansson and Hermansson, 2011 Zhu et al., 2018 Ma et al., 2022 Ouyang et al., 2021 Xu et al., 2024 Atherosclerosis (AS) is a chronic inflammatory vascular disease and the principal pathological basis of cardiovascular and cerebrovascular disorders. [Chen Xiaoying (2026)]
The current Migaku evidence database contains 1 reusable source document for Sesamin Lipid Markers Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Moreover, emerging evidence demonstrates that ferroptosis occurs in endothelial cells, vascular smooth muscle cells, and macrophages within atherosclerotic lesions, suggesting a more direct contribution to plaque vulnerability and vascular dysfunction than other cell death pathways (;;). [Chen Xiaoying (2026); evidence level 4]
- Accumulating evidence indicates that mA modification and its regulatory enzymes, including METTL3 and FTO, play essential roles in vascular cell function, lipid metabolism, and inflammatory signaling during AS development (). [Chen Xiaoying (2026); evidence level 4]
- In this context, recent evidence indicates that SREBF1, traditionally known for its role in lipid metabolism, may exert context-dependent functions under oxidative stress, including regulation of ferroptosis-related antioxidant defenses (;). [Chen Xiaoying (2026); evidence level 4]
- Fan and Watanabe, 2022 Libby, 2021 Hansson and Hermansson, 2011 Zhu et al., 2018 Ma et al., 2022 Ouyang et al., 2021 Xu et al., 2024 Atherosclerosis (AS) is a chronic inflammatory vascular disease and the principal pathological basis of cardiovascular and cerebrovascular disorders. [Chen Xiaoying (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources